|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 95, 807-810, Copyright © 1989 by American College of Chest Physicians
REVIEWS |
JR Thurn and K Henry
Department of Medicine, St. Paul-Ramsey Medical Center, Minneapolis 55101.
Influenza A results in considerable morbidity, mortality and economic costs. Although immunoprophylaxis and chemoprophylaxis are targeted toward high-risk groups, persons with human immunodeficiency virus (HIV) infection have not been widely recognized as being at increased risk of influenza infection. We report a case of influenza A pneumonitis in a patient infected with HIV. The literature on influenza immunization of HIV-infected patients is reviewed and the implications for public health are discussed. Consideration should be given to influenza immunization and chemoprophylaxis in this enlarging population. Further investigation of the pathogenesis and epidemiology of influenza in HIV-infected patients is warranted.
This article has been cited by other articles:
![]() |
J. C. Lin and K. L. Nichol Excess Mortality Due to Pneumonia or Influenza During Influenza Seasons Among Persons With Acquired Immunodeficiency Syndrome Arch Intern Med, February 12, 2001; 161(3): 441 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Neuzil, G. W. Reed, E. F. Mitchel Jr, and M. R. Griffin Influenza-Associated Morbidity and Mortality in Young and Middle-Aged Women JAMA, March 10, 1999; 281(10): 901 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Benne, F. P. Kroon, M. Harmsen, L. Tavares, C. A. Kraaijeveld, and J. C. De Jong Comparison of Neutralizing and Hemagglutination-Inhibiting Antibody Responses to Influenza A Virus Vaccination of Human Immunodeficiency Virus-Infected Individuals Clin. Vaccine Immunol., January 1, 1998; 5(1): 114 - 117. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |